The Paragon Report Provides Stock Research on China Digital TV and Giant Interactive Group
Continue ReadingTag: stock-market
Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry-s Success in 2012
Five Star Equities Provides Stock Research on Array Biopharma and Sunesis Pharmaceuticals
Continue ReadingHigh Dividend Paying Companies Losing Luster Among Investors as Dividend Tax Rate Set to Increase
Five Star Equities Provides Stock Research on Frontier Communications and Windstream
Continue ReadingImproving Trend in FDA First Cycle Review Approvals a Major Factor for Biotech Industry-s Success in 2012
Five Star Equities Provides Stock Research on Alexza Pharmaceuticals and EntreMed
Continue ReadingChinese Equities Receive a Boost as Manufacturing in China Rises for the First Time in 13 Months
The Paragon Report Provides Stock Research on Cleantech Solutions International and Zhongpin
Continue ReadingConsumer Spending Could Drop by as Much as $200 Billion if Upcoming “Fiscal Cliff” Is Not Avoided
The Paragon Report Provides Stock Research on The Coca-Cola and Mondelez International
Continue ReadingChina to Provide Subsidies to Rare Earth Producers in Attempts to Boost Struggling Industry
Five Star Equities Provides Stock Research on Lynas and Quest Rare Minerals
Continue ReadingDemand for Rare Earths Expected to Top 200,000 Tons by 2020 — Molycorp Shares Surge as Executives Purchase Shares
Five Star Equities Provides Stock Research on Molycorp and Rare Element Resources
Continue ReadingBiotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases
Five Star Equities Provides Stock Research on Cytokinetics and Galectin Therapeutics
Continue ReadingFDA on Pace to Approve More New Drugs in 2012 Than the 30 Approved in 2011
Five Star Equities Provides Stock Research on CytRx and ZIOPHARM Oncology
Continue Reading